Clinical Trials Logo

Mucositis clinical trials

View clinical trials related to Mucositis.

Filter by:

NCT ID: NCT02075749 Completed - Mucositis Clinical Trials

Comparing Triamcinolone Acetonide Mucoadhesive Films With Licorice Mucoadhesive Films

Start date: May 2013
Phase: Phase 1/Phase 2
Study type: Interventional

Abstract: Background: Complementary and alternative medicine (CAM) had proven efficacy in pain relief, correction of nutritional status and improving the performance status. However, lack of standardization is the major obstacle for any scientific evaluation of any CAM trial. Mucositis is a major complication of irradiation in head and neck (H&N) tumors, the addition of chemotherapy to irradiation may enhance this dose limiting problem. Licorice is a strong demulcent that had been effectively used in treatment of peptic ulcer. The main purpose of this study was to compare the therapeutic safety and efficacy of T. and L. mucoadhesive films on oral mucositis in terms of pain control and/or ulcer treatment. Methods and Materials: the study was a double-blind, randomized prospective trial of two types of mucoadhesive films in the management of oral mucositis occurred during head and neck cancer ( HNC ) radiotherapy. oral mucositis was assessed using a quantitative scale (WHO scales) and symptoms were assessed using visual analogue scales (VAS). 60 patients were enrolled in the study; there were 30 patients in the Triamcinolone (T) and 30 in the Licorice (L) group. In the T- group, patients received triamcinolone acetonide mucoadhesive films containing 1mg of the drug and patients in the L- group received licorice mucoadhesive films, an herbal agent. Data were collected at baseline, then twice a week for 4 weeks.

NCT ID: NCT02058849 Completed - Mucositis Clinical Trials

Randomized Study of Beet Root in Locally Advanced Squamous Cell Cancer of the Head and Neck

Start date: December 2014
Phase: Phase 2
Study type: Interventional

The objective of the current proposal is to determine if concentrated beet root could improve medical treatment compliance as defined by completion of radiotherapy and 3 cycles of chemoradiation without dose reduction, preserve fat-free mass, and strength while reducing mucositis. The investigators central hypothesis is that dietary nitrate supplementation in head and neck cancer patients receiving aggressive medical care will improve compliance with medical treatment by attenuating the loss of muscle mass and strength and reducing symptoms (mucositis) associated with treatment compared to patients receiving standard care with placebo.

NCT ID: NCT02050503 Completed - Clinical trials for Head and Neck Cancer

Intranasal Transmucosal Fentanyl Pectin for Breakthrough Cancer Pain in Radiation-induced Oropharyngeal Mucositis

CP073
Start date: December 2012
Phase: N/A
Study type: Observational

An open-label, non-randomized study to assess the titration, safety and efficacy of intranasal fentanyl pectin nasal spray for the treatment of secondary breakthrough pain secondary to radiation-induced mucositis in patients with confirmed tolerance of opioid therapy for chronic pain. Study objectives include assessment of breakthrough pain episodes related with food intake in patients with mucositis secondary to radiotherapy or radio-chemotherapy for head and neck tumors

NCT ID: NCT02050373 Completed - Oral Mucositis Clinical Trials

Low-level Laser Therapy on Inflammatory Mediators During Chemotherapy-induced Oral Mucositis

LLLTHSCT
Start date: January 2012
Phase: N/A
Study type: Interventional

The aim of the study is to evaluate the effect of low-level laser therapy (LLLT) on the severity of oral mucositis (OM) and inflammatory mediators (pro- and anti-inflammatory cytokines, metalloproteinases and growth factors) levels in saliva and blood; furthermore, analyze the effect of LLLT in product modulation of oxidative stress and cell damage from the oral mucosa transplant patients.

NCT ID: NCT02023853 Completed - Clinical trials for Peri-Implantitis and Peri-implant Mucositis

Non Surgical Treatment of Periimplantitis

Start date: December 2013
Phase: Phase 4
Study type: Interventional

20 consecutive adult implant patients, presenting the signs of peri-implant mucositis (probing depth ≥4 mm combined with bleeding and/or pus on probing) or initial peri-implantitis (probing depth ≥4 mm, bleeding and suppuration plus radiographic loss of supporting bone ≤30% compared with the situation after implant placement) will be included. Sites will be treated by ultrasonic debridement of the pocket, performed using a piezoceramic ultrasonic device. For the purpose, a Tip will be connected to the Handpiece Led (5 minutes/pocket) . Then, it will be followed by the subgingival use of erythritol powder applied by the use of Handpiece connected to an airflow unit 2x5 seconds/pocket. At this time the subgingival delivery of metronidazole gel will be provided. After instrumentation, patients will rinse with chlorhexidine 0.20% 3 times/day for 2 weeks. At baseline, 1 month, 3 months and 6 months the following parameters will be evaluated: Probing Pocket depth (PPD), Bleeding on Probing (BoP), Clinical Attachment Level (CAL).

NCT ID: NCT01974596 Completed - Mucositis Clinical Trials

Use of Probiotics in Oral Health of Patients With Dental Implants

Start date: January 2008
Phase: Phase 2
Study type: Interventional

The aim of this study was evaluate the effects of the oral probiotic Lactobacillus reuteri Prodentis upon the peri-implant health of edentulous patients with dental implants and peri-implant mucositis, establishing comparisons versus implants without peri-implant disease. The hypothesis of the study is that using these probiotics are going to improve the periimplant health.

NCT ID: NCT01941992 Completed - Oral Mucositis Clinical Trials

Role of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer Patients

ROSAM
Start date: December 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to: - evaluate the activity of SAMITAL in reducing the incidence of severe mucositis in head-and-neck cancer patients undergoing chemo-radiotherapy. - assess tolerability of SAMITAL and the impact on patients reported outcomes.

NCT ID: NCT01941797 Completed - Gingivitis Clinical Trials

Experimental Peri-implant Mucositis in Humans

Start date: September 2012
Phase: N/A
Study type: Interventional

This is a pilot study. The investigators hypothesize that the peri-implant soft tissue response to de novo plaque accumulation is similar to that of normal gingival tissue in the same subjects. The investigators propose to conduct a controlled clinical trial to evaluate peri-implant soft tissue response to de novo plaque accumulation in comparison to the response of gingival tissue in the same subjects

NCT ID: NCT01903018 Completed - Clinical trials for Radiation Induced Mucositis in Head and Neck Cancer

A Study to Assess Radiation Induced Mucositis in Patients of Head and Neck Cancer Administered Chemo-Radiation With or Without P276-00

Start date: July 2012
Phase: Phase 2
Study type: Interventional

A Clinical Study to Assess Radiation Induced Mucositis in Subjects with Locally Advanced Squamous Cell Carcinoma of the Head and Neck

NCT ID: NCT01898091 Completed - Oral Mucositis Clinical Trials

Herbal Mouthrinse for Oral Mucositis Study

OM
Start date: July 2013
Phase: Phase 2
Study type: Interventional

This study involves adults receiving radiation therapy for head and neck cancer and will test whether or not the study mouthrinse may lessen oral mucositis.